if they pay up big they would then have to commercialize the indications for financial reasons
TRU DAT!!! Aint no way they would be able to bury a 4-5 billion bill for MS, a 1.5-3 Billion bill for Parkinsons or a 10-20 Billion bill for Alz (with accelerated approval factored in of course) from shareholders!
Those that think we are sitting high if we get to $100 a share are cutting themselves way short IMO. Only time will tell though.